Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 22:10:1657-69.
doi: 10.3762/bjoc.10.173. eCollection 2014.

The chemoenzymatic synthesis of clofarabine and related 2'-deoxyfluoroarabinosyl nucleosides: the electronic and stereochemical factors determining substrate recognition by E. coli nucleoside phosphorylases

Affiliations

The chemoenzymatic synthesis of clofarabine and related 2'-deoxyfluoroarabinosyl nucleosides: the electronic and stereochemical factors determining substrate recognition by E. coli nucleoside phosphorylases

Ilja V Fateev et al. Beilstein J Org Chem. .

Abstract

Two approaches to the synthesis of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine (1, clofarabine) were studied. The first approach consists in the chemical synthesis of 2-deoxy-2-fluoro-α-D-arabinofuranose-1-phosphate (12a, (2F)Ara-1P) via three step conversion of 1,3,5-tri-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranose (9) into the phosphate 12a without isolation of intermediary products. Condensation of 12a with 2-chloroadenine catalyzed by the recombinant E. coli purine nucleoside phosphorylase (PNP) resulted in the formation of clofarabine in 67% yield. The reaction was also studied with a number of purine bases (2-aminoadenine and hypoxanthine), their analogues (5-aza-7-deazaguanine and 8-aza-7-deazahypoxanthine) and thymine. The results were compared with those of a similar reaction with α-D-arabinofuranose-1-phosphate (13a, Ara-1P). Differences of the reactivity of various substrates were analyzed by ab initio calculations in terms of the electronic structure (natural purines vs analogues) and stereochemical features ((2F)Ara-1P vs Ara-1P) of the studied compounds to determine the substrate recognition by E. coli nucleoside phosphorylases. The second approach starts with the cascade one-pot enzymatic transformation of 2-deoxy-2-fluoro-D-arabinose into the phosphate 12a, followed by its condensation with 2-chloroadenine thereby affording clofarabine in ca. 48% yield in 24 h. The following recombinant E. coli enzymes catalyze the sequential conversion of 2-deoxy-2-fluoro-D-arabinose into the phosphate 12a: ribokinase (2-deoxy-2-fluoro-D-arabinofuranose-5-phosphate), phosphopentomutase (PPN; no 1,6-diphosphates of D-hexoses as co-factors required) (12a), and finally PNP. The substrate activities of D-arabinose, D-ribose and D-xylose in the similar cascade syntheses of the relevant 2-chloroadenine nucleosides were studied and compared with the activities of 2-deoxy-2-fluoro-D-arabinose. As expected, D-ribose exhibited the best substrate activity [90% yield of 2-chloroadenosine (8) in 30 min], D-arabinose reached an equilibrium at a concentration of ca. 1:1 of a starting base and the formed 2-chloro-9-(β-D-arabinofuranosyl)adenine (6) in 45 min, the formation of 2-chloro-9-(β-D-xylofuranosyl)adenine (7) proceeded very slowly attaining ca. 8% yield in 48 h.

Keywords: chemoenzymatic synthesis; clofarabine; nucleoside phosphorylases; phosphopentomutase; recombinant E. coli ribokinase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structures of purine nucleosides studied in the chemoenzymatic synthesis and in a cascade one-pot transformation of D-pentoses into nucleosides of 2-chloroadenine catalyzed by the recombinant E. coli ribokinase (RK), phosphopentomutase (PPM) and purine nucleoside phosphorylase (PNP) (purine numbering was used throughout of the manuscript).
Scheme 1
Scheme 1
Chemical synthesis of 2-deoxy-2-fluoro-α/β-D-arabinofuranose-1-phosphates (12a,b). Reagents and conditions: (a) 9/AcBr/H3PO4, 50 °C, 5 h; (b) intermediate 10/dioxane/n-Bu3N, rt, 12–18 h; (c) intermediate 11/water/LiOH, rt, 1 h.
Figure 2
Figure 2
The structures of 1-phosphates of α-D-arabinofuranose (13a; AraFur-1P) and β-D-arabinopyranose (13b; AraPyr-1P).
Figure 3
Figure 3
Geometry optimization of 1-phosphates of 2-deoxy-2-fluoro-α-D-arabinofuranose (12a) and the β-anomer 12b [dilithium salts; HyperChem 8.1; AMBER Force Field starting approximation, then the ab initio calculations (3-21G/total charge equal to zero; Polak–Ribiere conjugate gradient)].
Figure 4
Figure 4
Progress of the formation of 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-2-chloroadenine (1), 2-amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine (2a) and 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)hypoxanthine (3a) (Reaction conditions are shown in Table 1).
Figure 5
Figure 5
Clofarabine content in the reaction mixture vs time (hours) of the reaction.
Scheme 2
Scheme 2
Suggested mechanism of purine nucleoside synthesis catalyzed by E. coli purine nucleoside phosphorylase.
Figure 6
Figure 6
Progress of the formation of β-D-arabinofuranosides and 2-deoxy-2-fluoro-β-D-arabinofuranosides of 5-aza-7-deazaguanine 4b and 4a, and 8-aza-7-deazahypoxanthine 5b and 5a. Reaction conditions: reactions (1 mL) were performed in the presence of 2 μmol heterocyclic base and 4 μmol phosphate 12a (as a mixture of two anomers, so that the real quantity of the substrate 12a is half of the indicated quantity, i.e., 2 μmol) or 10 μmol arabinose-1-phosphate (real quantity of α-D-arabinofuranose-1-phosphate is 2 μmol) in water at 50 °C for 24 h with addition of 3.9 units PNP; the following preparations of E. coli enzymes have been employed: PNP (52 units/mg; 15 mg/mL).
Figure 7
Figure 7
Tautomeric structures of 5-aza-7-deazaguanine (17).
Figure 8
Figure 8
Progress of the formation of clofarabine (1), 9-(β-D-arabinofuranosyl)-2-chloroadenine (6), 9-(β-D-xylofuranosyl)-2-chloroadenine (7) and 2-cloroadenosine (8).

Similar articles

Cited by

References

    1. Pankiewicz K W. Carbohydr Res. 2000;327:87–105. doi: 10.1016/S0008-6215(00)00089-6. - DOI - PubMed
    1. Chu C K, Matulic-Adamic J, Huang J-T, Chou T-C, Burchenal J H, Fox J J, Watanabe K A. Chem Pharm Bull. 1989;37:336–339. doi: 10.1248/cpb.37.336. - DOI - PubMed
    1. Montgomery J A, Shortnacy-Fowler A T, Clayton S D, Riordan J M, Secrist J A., III J Med Chem. 1992;35:397–401. doi: 10.1021/jm00080a029. - DOI - PubMed
    1. Smee D F, Sidwell R W. Nucleosides, Nucleotides Nucleic Acids. 2004;23:375–383. doi: 10.1081/NCN-120028334. - DOI - PubMed
    1. Bonate P L, Arthaud L, Cantrell W R, Jr, Stephenson K, Secrist J A, III, Weitman S. Nat Rev Drug Discovery. 2006;5:855–863. doi: 10.1038/nrd2055. - DOI - PubMed

LinkOut - more resources